These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8525772)

  • 1. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
    Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Fenaux P
    Acta Haematol; 1993; 89 Suppl 1():22-7. PubMed ID: 8475669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.
    Fenaux P; Chastang C; Degos L
    Leukemia; 1994; 8 Suppl 2():S42-7. PubMed ID: 7815836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
    Castaigne S; Degos L
    C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
    Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
    Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating therapy in acute myeloid leukemia.
    Tallman MS
    Leukemia; 1996 Aug; 10(8):1262-8. PubMed ID: 8709629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute promyelocytic leukaemia.
    Fenaux P; Chomienne C; Degos L
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
    Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid syndrome in acute promyelocytic leukemia.
    Sentero D; Hosenpud J
    Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
    Yang J; Han Z; Pei M; Xiao N
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
    Lanvers C; Reinhardt D; Dübbers A; Wagner-Bohn A; Creutzig U; Ritter J; Boos J
    Med Pediatr Oncol; 2003 May; 40(5):293-301. PubMed ID: 12652617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
    Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.